RxDoctor Payments Data

Denise Davis

Physician Assistant · Madison Heights, MINPI 1790704062

Payments from drug & device makers

$1,393in general payments, 2019–2025

Across 24 payments — averaging $58.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$264
  • Bayer$234
  • Inspire Medical Systems, Inc.$160
  • Alnylam Pharmaceuticals Inc.$127
  • Axsome Therapeutics, Inc.$125
  • E.r. Squibb & Sons, L.L.C.$125
  • plus $358 from 10 others

What the payments were for

  • Food & beverage$1,393100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,393 in reported general payments places this provider in the 80th percentile of 5,453 physician assistant providers in Michigan.

See all physician assistant providers in Michigan

Medicare billing

Part B allowed, 2024
$35,646
Medicare patients
95
Services billed
369

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LokelmaSodium Zirconium Cyclosilicate13$9,981
TradjentaLinagliptin33$8,623
EliquisApixaban23$6,843
Lubiprostone23$4,114
Breo ElliptaFluticasone/Vilanterol11$2,662
Lantus SolostarInsulin Glargine,hum.Rec.Anlog16$1,539
Novolog FlexpenInsulin Aspart11$1,093
Levothyroxine Sodium59$622
Pregabalin12$564
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen40$545
Hydralazine Hcl17$429
Metoprolol Succinate20$390
Fluticasone Propionate15$365
Furosemide54$323
EnuloseLactulose12$319

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaLokelma$88$9,98113 claims
Boehringer IngelheimTradjenta$42$8,62333 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 5,453 physician assistant providers in Michigan.

Other physician assistant in Madison Heights

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →